Sex ratio in dementia with Lewy bodies balanced between Alzheimer’s disease and Parkinson’s disease dementia: a cross-sectional study
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1758-9193
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Sex ratio in dementia with Lewy bodies balanced between Alzheimer’s disease and Parkinson’s disease dementia: a cross-sectional study ; volume:10 ; number:1 ; day:12 ; month:9 ; year:2018 ; pages:1-10 ; date:12.2018
Alzheimer's research & therapy ; 10, Heft 1 (12.9.2018), 1-10, 12.2018
- Urheber
-
Mouton, A.
- Beteiligte Personen und Organisationen
-
Blanc, F.
Gros, A.
Manera, V.
Fabre, R.
Sauleau, E.
Gomez-Luporsi, I.
Tifratene, K.
Friedman, L.
Thümmler, S.
Pradier, C.
Robert, P. H.
David, R.
SpringerLink (Online service)
- DOI
-
10.1186/s13195-018-0417-4
- URN
-
urn:nbn:de:101:1-2018102823501623372039
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 11:03 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Mouton, A.
- Blanc, F.
- Gros, A.
- Manera, V.
- Fabre, R.
- Sauleau, E.
- Gomez-Luporsi, I.
- Tifratene, K.
- Friedman, L.
- Thümmler, S.
- Pradier, C.
- Robert, P. H.
- David, R.
- SpringerLink (Online service)
Ähnliche Objekte (12)
Dementia / Alzheimer's Disease
Relevance of plasma biomarkers to pathologies in Alzheimer’s disease, Parkinson’s disease and frontotemporal dementia
Differential diagnosis between patients with probable Alzheimer’s disease, Parkinson’s disease dementia, or dementia with Lewy bodies and frontotemporal dementia, behavioral variant, using quantitative electroencephalographic features
Machine learning identified an Alzheimer’s disease-related FDG-PET pattern which is also expressed in Lewy body dementia and Parkinson’s disease dementia
Levels of cerebrospinal fluid α-synuclein oligomers are increased in Parkinson’s disease with dementia and dementia with Lewy bodies compared to Alzheimer’s disease
Are dementia with Lewy bodies and Parkinson’s disease dementia the same disease?
Parkinson’s disease and Alzheimer’s disease: a Mendelian randomization study
RBC acetyl cholinesterase: A poor man’s early diagnostic biomarker for familial alzheimer’s and Parkinson’s disease dementia
Psychiatric Adverse Events of Acetylcholinesterase Inhibitors in Alzheimer’s Disease and Parkinson’s Dementia: Systematic Review and Meta-Analysis
Distinct tau and alpha-synuclein molecular signatures in Alzheimer’s disease with and without Lewy bodies and Parkinson’s disease with dementia
Alzheimer’s disease, dementia, and stem cell therapy
Presenilins in Alzheimer’s disease and frontotemporal dementia
Dementia / Alzheimer's Disease
Relevance of plasma biomarkers to pathologies in Alzheimer’s disease, Parkinson’s disease and frontotemporal dementia
Differential diagnosis between patients with probable Alzheimer’s disease, Parkinson’s disease dementia, or dementia with Lewy bodies and frontotemporal dementia, behavioral variant, using quantitative electroencephalographic features
Machine learning identified an Alzheimer’s disease-related FDG-PET pattern which is also expressed in Lewy body dementia and Parkinson’s disease dementia
Levels of cerebrospinal fluid α-synuclein oligomers are increased in Parkinson’s disease with dementia and dementia with Lewy bodies compared to Alzheimer’s disease
Are dementia with Lewy bodies and Parkinson’s disease dementia the same disease?
Parkinson’s disease and Alzheimer’s disease: a Mendelian randomization study
RBC acetyl cholinesterase: A poor man’s early diagnostic biomarker for familial alzheimer’s and Parkinson’s disease dementia
Psychiatric Adverse Events of Acetylcholinesterase Inhibitors in Alzheimer’s Disease and Parkinson’s Dementia: Systematic Review and Meta-Analysis
Distinct tau and alpha-synuclein molecular signatures in Alzheimer’s disease with and without Lewy bodies and Parkinson’s disease with dementia
Alzheimer’s disease, dementia, and stem cell therapy
Presenilins in Alzheimer’s disease and frontotemporal dementia
Dementia / Alzheimer's Disease
Relevance of plasma biomarkers to pathologies in Alzheimer’s disease, Parkinson’s disease and frontotemporal dementia
Differential diagnosis between patients with probable Alzheimer’s disease, Parkinson’s disease dementia, or dementia with Lewy bodies and frontotemporal dementia, behavioral variant, using quantitative electroencephalographic features
Machine learning identified an Alzheimer’s disease-related FDG-PET pattern which is also expressed in Lewy body dementia and Parkinson’s disease dementia
Levels of cerebrospinal fluid α-synuclein oligomers are increased in Parkinson’s disease with dementia and dementia with Lewy bodies compared to Alzheimer’s disease
Are dementia with Lewy bodies and Parkinson’s disease dementia the same disease?
Parkinson’s disease and Alzheimer’s disease: a Mendelian randomization study
RBC acetyl cholinesterase: A poor man’s early diagnostic biomarker for familial alzheimer’s and Parkinson’s disease dementia
Psychiatric Adverse Events of Acetylcholinesterase Inhibitors in Alzheimer’s Disease and Parkinson’s Dementia: Systematic Review and Meta-Analysis
Distinct tau and alpha-synuclein molecular signatures in Alzheimer’s disease with and without Lewy bodies and Parkinson’s disease with dementia
Alzheimer’s disease, dementia, and stem cell therapy